Fenofibrate ameliorates diabetic and dyslipidemic profiles in KKAy mice partly via down-regulation of 11β-HSD1, PEPCK and DGAT2.
Author:
Publisher
Elsevier BV
Subject
Pharmacology
Reference48 articles.
1. Type 2 diabetes and metabolic syndrome are associated with increased expression of 11beta hydroxysteroid dehydrogenase 1 in obese subjects;Alberti;Int. J. Obes. (Lond),2007
2. Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains;Alberts;Endocrinology,2003
3. Lovastatin therapy reduces low density lipoprotein apo B level in subjects with combined hyperlipidemia by reducing the production of apoB containing lipoproteins: implications for the pathophysiology of apo B production;Arad;J. Lipid Res.,1990
4. Fenofibrate: influence on circulating lipids and side-effects in medium and long-term clinical use;Blane,1986
5. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-α, -γ, and -δ in the adult rat;Braissant;Endocrinology,1996
Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A comparative study of the hypolipidemic effects and mechanisms of action of Laminaria japonica- and Ascophyllum nodosum-derived fucoidans in apolipoprotein E-deficient mice;Food & Function;2024
2. Long-Term Fenofibrate Treatment Stimulates the Phenotypic Microevolution of Prostate Cancer Cells In Vitro;Pharmaceuticals;2022-10-26
3. Interactions between nuclear receptors glucocorticoid receptor α and peroxisome proliferator–activated receptor α form a negative feedback loop;Reviews in Endocrine and Metabolic Disorders;2022-04-27
4. Fenofibrate, a peroxisome proliferator-activated receptor-alpha agonist, blocks steatosis and alters the inflammatory response in a mouse model of inflammation-dioxin interaction;Chemico-Biological Interactions;2021-08
5. Discovery of analogues of non-β oxidizable long-chain dicarboxylic fatty acids as dual inhibitors of fatty acids and cholesterol synthesis: Efficacy of lead compound in hyperlipidemic hamsters reveals novel mechanism;Nutrition, Metabolism and Cardiovascular Diseases;2021-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3